COVID-19 treatments to enter the market with a hefty price tag

  • 📰 KING5Seattle
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 53%

Malaysia News News

Malaysia Malaysia Latest News,Malaysia Malaysia Headlines

Pfizer said it is increasing the price of the drug.

WASHINGTON — The COVID-19 treatments millions of Americans have taken for free from the federal government will enter the private market next week with a hefty price tag.at $1,390, but Americans can still access the pills at no cost -- for now. The less commonly used COVID-19 treatment Lagevrio, manufactured by Merck, also will hit the market next week.

Under a new agreement, reached last month between Pfizer and the federal government, people on Medicaid, Medicare or those who are without medical insurance will not pay any out-of-pocket costs for the treatment through the end of next year. Pfizer will also offer copay assistance for the treatment through 2028. The Department of Veterans Affairs, the Department of Defense and Indian Health Service will still be able to access Paxlovid the government has on hand.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 457. in MY
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Malaysia Malaysia Latest News, Malaysia Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

COVID-19 treatments to enter the market with a hefty price tagPfizer said it is increasing the price of the drug.
Source: KHOU - 🏆 330. / 59 Read more »

COVID-19 treatments to enter the market with a hefty price tagPfizer said it is increasing the price of the drug.
Source: WTHRcom - 🏆 329. / 59 Read more »

COVID-19 treatments to enter the market with a hefty price tagPfizer said it is increasing the price of the drug.
Source: KENS5 - 🏆 608. / 51 Read more »